ASHLEY SCHULTE: Open Payments
NPI 1467044131 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,385 in 61 payments from 18 companies in 2025. Trend: 2023 $1,424 · 2024 $1,662 · 2025 $1,385
Food & beverage: $1,385
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $317 |
| Amgen Inc. | 7 | $167 |
| LEO Pharma Inc. | 6 | $158 |
| Novartis Pharmaceuticals Corporation | 5 | $121 |
| GENZYME CORPORATION | 4 | $101 |
| Botanix SB Inc | 5 | $88 |
| Lilly USA, LLC | 3 | $82 |
| UCB, Inc. | 2 | $74 |
| Janssen Biotech, Inc. | 3 | $66 |
| Arcutis Biotherapeutics, Inc. | 2 | $37 |
Products named: SKYRIZI, OTEZLA, ADBRY, DUPIXENT, SOFDRA, EBGLYSS, Bimzelx, RINVOQ.
Industry payments across FL — which companies pay providers there.
